Japanese multimodality vendor Toshiba this month appointed Hiromitsu Igarashi as president of the company’s U.S. operation, Toshiba America Medical Systems, of Tustin, CA. Igarashi replaces Masamichi Katsurada, who has served as president of
Japanese multimodality vendor Toshiba this month appointed Hiromitsu Igarashi as president of the companys U.S. operation, Toshiba America Medical Systems, of Tustin, CA. Igarashi replaces Masamichi Katsurada, who has served as president of TAMS since 1996. Katsurada has been named to the post of vice president of Toshiba Medical Systems and will return to Japan.
Igarashi brings experience in the U.S. market to his new post from his two-year stint as president of South San Francisco, CA-based Toshiba America MRI. During his time at TAMI, Igarashi oversaw the global launch of Opart, Toshibas 0.35-tesla MRI system. Some 200 Oparts have been installed worldwide (SCAN 12/18/96).
© 1999 Miller Freeman, Inc.All rights reserved.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.